Glaxo Smith Kline

Type
Offshoring/Delocalisation
Country
United Kingdom
Region
South East (England); Berkshire, Buckinghamshire and Oxfordshire; Berkshire East
Location of affected unit(s)
Maidenhead
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
New offshoring locations
Various EU Locations
287 jobs
Number of planned job losses
Job loss
Announcement Date
24 June 2008
Employment effect (start)
24 June 2008
Foreseen end date
30 December 2010

Description

Pharmaceutical giant GlaxoSmithKline has announced that it is to cut 287 jobs (60% of its workforce) in Maidenhead by the end of 2010. Staff at the site were told that production would be moved to Eastern Europe. The company has blamed the job cuts on the loss of some patents and on increased competition. The site is not unionised so consultation has begun with employee representatives. The company announced that it would do everything it could to assist employees affected by the job losses.

Sources

  • 24 June 2008: BBC Website

Citation

Eurofound (2008), Glaxo Smith Kline, Offshoring/Delocalisation in United Kingdom, factsheet number 66807, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/66807.